Urinary-tract infections: etiology, microbiology, pathophysiology, diagnosis and management

Area of Science:

• Urology
• Infectious Diseases
• Microbiology

Background:

• Rising incidence of urinary-tract infections (UTIs) linked to increased longevity and pathogen drug resistance.
• Bacterial L forms and urothelium resistance contribute to UTI prevalence.
• Recurrent UTIs, often re-infections, present significant treatment challenges.

Purpose of the Study:

• To outline the diagnosis, management, and chemotherapy of various UTI types.
• To evaluate the efficacy of antimicrobial agents and drugs at different urinary tract sites.
• To assess the effectiveness of current short-course prophylaxis plans.

Main Methods:

• Classification of UTIs into asymptomatic bacteriuria, acute uncomplicated, acute complicated, and recurrent infections.
• Utilizing antibody-coated bacteria (ACB) and bladder-washout tests for infection site localization.
• Reviewing treatment outcomes for upper-tract, bladder, and prostatitis infections.

Main Results:

• Escherichia coli is the most common uropathogen; Pseudomonas is the most virulent.
• Recurrent infections are typically refractory to treatment and caused by different pathogens.
• Upper-tract infections are difficult to cure; bladder infections respond better; prostatitis is challenging due to drug penetration.

Conclusions:

• Effective management of UTIs requires accurate diagnosis and site-specific treatment strategies.
• Current short-course prophylaxis approaches are not meeting expectations.
• Understanding pathogen characteristics and host factors is crucial for combating UTIs.